Pharmaceutical / Drug Definition :
Potentiates effects of norepinephrine and serotonin by blocking their synaptic reuptake. Also exerts anticholinergic activity by disrupting muscarinic receptors.
FDA Detentions
Mirtazapine (Mirtazapine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Mirtazapine (Mirtazapine Suppliers)
- Processors Mirtazapine
- Repackers Mirtazapine
- Relabelers Mirtazapine
- Exporters Mirtazapine
- Importers Mirtazapine
For more information about Mirtazapine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
